REP 2139

nucleic acid polymer · Replicor Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REP 2139, covering 2025-02-17 to 2025-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Replicor Compassionate Access Program